Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Jan 5, 2025
Date Accepted: Jul 24, 2025
Comment On"Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial"
ABSTRACT
The article "Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial" provided a potential approach to improve the clinical outcomes of the ovarian cancer patients undergoing chemotherapy especially in China. But the authors interpreted the Figure 7 as the "Imflammation-Related Blood Indices" is not accurate considering the adverse event bone marrow suppression(BMS) within patients recieving chemotherapy seperately or combined with others. So we suggest it might be more accurate to describe Figure 7 simply as “the changes in blood cells”, and the potential benefit for improving BMS should also be described in this section.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.